Our Vision is to prematurely identify and prevent all joint replacement rejection and autoimmune disease before the patient is compromised. New cutting edge studies regarding L-form (soft cell) bacteria has proved that previously undiscovered bacteria in the human body is responsible for “random rejection” of joint replacements and transplants. With this new understanding, we will be identifying this bacteria and solving the problem that has vexed medical professionals for years.